Efficacy and Specificity of a Monoclonal Antibody-Drug Conjugate in Chemotherapy by Intratumoral Injection
β Scribed by Kitamura, Kazuya ;Takahashi, Toshio ;Miyagaki, Takuya ;Yamaoka, Nobuki ;Tsurumi, Hiroshi ;Ohtsuji, Eigo ;Kamiguchi, Michiko ;Noguchi, Akinori ;Yamaguchi, Toshiharu
- Book ID
- 108579496
- Publisher
- Wiley (Blackwell Publishing)
- Year
- 1992
- Tongue
- English
- Weight
- 363 KB
- Volume
- 83
- Category
- Article
- ISSN
- 0910-5050
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
A panel of three hybridomas has been isolated each of which secretes a single species of monoclonal antibody (MoAb) directed against the KS1/4 tumor-associated antigen originally described by Varki et al. (Cancer Res 44: 681, 1984). These MoAbs were designated L1-(IgG2b), L2-(IgG1), and L4-(IgG2a)KS
We describe a novel version of antibody-directed enzyme prodrug therapy (ADEPT), with the use of amygdalin as prodrug. Amygdalin is a naturally occurring cyanogenic glycoside, which can be cleaved by sweet almond β€-glucosidase to yield free cyanide. If amygdalin could be activated specifically at th